Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Caring BrandsCABR +3.57%6 EV-to-EBITDA is -2.55 as of Jul. 27, 2026. GuruFocus rates CABR with a GF Score™ of 6/100. The stock has 4 warning signs investors should review. Among 742 Drug Manufacturers companies, Caring Brands ranks worse than 134770.75% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Caring Brands's enterprise value is $11.05 Mil.
Caring Brands's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-4.34 Mil. Therefore, Caring Brands's EV-to-EBITDA for today is -2.55.
The historical rank and industry rank for Caring Brands's EV-to-EBITDA or its related term are showing as below:
CABR'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -2.55 Med: 0 Max: 0
Current: -2.55
CABR's EV-to-EBITDA is ranked worse than 100% of 742
companies
in the Drug Manufacturers industry
Industry Median: 12.93
vs CABR: -2.55
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Caring Brands (NAS:CABR) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Caring Brands's PE Ratio (TTM) for today is calculated as:
Caring Brands's share price for today is $1.45.
Caring Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.690.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Caring Brands's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Caring Brands's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Caring Brands EV-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Caring Brands's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Caring Brands's EV-to-EBITDA falls into.
Caring Brands's current Enterprise Value is $11.05 Mil.
Caring Brands's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.34 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Caring Brands (CABR) has a EV-to-EBITDA of -2.55 as of Jul. 27, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Caring Brands. According to the industry distribution chart, Caring Brands ranks #999999 out of 742 companies in the Drug Manufacturers industry.
Is Caring Brands' EV-to-EBITDA too high?
Caring Brands' current EV-to-EBITDA is -2.55. Based on the distribution chart, Caring Brands ranks #999999 out of 742 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Caring Brands has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Caring Brands' EV-to-EBITDA compare to IGPK and HYEX?
According to the Drug Manufacturers industry distribution chart, Caring Brands ranks #999999 out of 742 companies for EV-to-EBITDA. This places Caring Brands in the lower half of its industry. The industry median EV-to-EBITDA is 12.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 12.93, based on 742 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Caring Brands. For the Drug Manufacturers industry, the median EV-to-EBITDA is 12.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Caring Brands's current EV-to-EBITDA is -2.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caring Brands stock overvalued right now?
Caring Brands (CABR) has a current EV-to-EBITDA of -2.55. The current EV-to-EBITDA is -2.55. Caring Brands' overall GF Score™ is 6/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Caring Brands (CABR), the current EV-to-EBITDA is -2.55 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Caring Brands Inc is a wellness consumer products company. It offers several over-the-counter (OTC) and cosmetic consumer products. Its product pipeline includes a diverse products, such as hair loss treatments, eczema and psoriasis treatments, vitiligo solutions, a jellyfish sting protective suncare line, and women's sexual wellness products, catering to diverse health and wellness needs. It operates in a single segment.
6GF Score
Get the complete analysis for CABR
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CABR has been successfully added to your 
